SCHEMBL4630397

SCHEMBL4630397

CC(C)(C)OC(=O)NN1CCCC([C]=O)C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
BTK Q06187 2/20 0.35
JAK3 P52333 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
GAA P10253 1/20 0.34
EPHX1 P07099 2/20 0.33
CYP2C9 P11712 1/20 0.33
HSD11B1 P28845 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
TSHR P16473 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27865006 0.81 CTSK (0.43) CTSKCA1CA2BTKJAK3
SCHEMBL28206821 0.81 CTSK (0.43) CTSKCA1CA2BTKJAK3
SCHEMBL18563164 0.79 CA1 (0.42) CTSKCA1CA2BTKJAK3
SCHEMBL26045207 0.79 CA1 (0.42) CTSKCA1CA2BTKJAK3
SCHEMBL4629909 0.79 CA1 (0.33) CA1CA2L3MBTL1
SCHEMBL22978707 0.78 BTK (0.51) CTSKCA1CA2BTKKMT2A
SCHEMBL8177527 0.78 CTSK (0.48) CTSKCA1CA2BTKJAK3
SCHEMBL8177523 0.78 CTSK (0.48) CTSKCA1CA2BTKJAK3
SCHEMBL5664610 0.77 NR1H2 (0.41) CTSKCA1CA2KMT2AMEN1
SCHEMBL27710985 0.77 CA1 (0.40) CTSKCA1CA2BTKJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed